Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Diagnosis, Computer-Assisted × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Disease 1

Interventions

pembrolizumab 169 Carboplatin 125 Paclitaxel 86 Cisplatin 82 Gemcitabine 73 Pemetrexed 67 Bevacizumab 61 Cyclophosphamide 50 Docetaxel 49 Oxaliplatin 42 Fluorouracil 41 Dexamethasone 41 durvalumab 40 Nivolumab 40 Cetuximab 37 Fulvestrant 36 Capecitabine 35 130-nm albumin-bound paclitaxel 35 Lenalidomide 34 Leucovorin 32 atezolizumab 31 fludarabine 30 Rituximab 30 Prednisone 30 venetoclax 27 Trastuzumab 24 enzalutamide 23 Doxorubicin 23 Letrozole 22 ribociclib 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

105 enrolled 15 charts

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡